[1] RYGIEL K. Hypertriglyceridemia——Common causes prevention and treatment strategies[J]. Curr Cardiol Rev, 2018,14(1):67-76. [2] NORATA G D, TSIMIKAS S, PIRILLO A, et al. Apolipoprotein C-Ⅲ:from pathophysiology to pharmacology[J]. Trends Pharmacol Sci, 2015,36(10):675-687. [3] GAUDET D, ALEXANDER V J, KASTELEIN J J, et al. Antisense inhibition of apolipoprotein C-Ⅲ in patients with hypertriglyceridemia[J]. N Engl J Med, 2015, 373(5):438-447. [4] FISCHER S C P M,PINTO S P,LINSL C D A S,et al. Association of multiple genetic variants with the extension and severity of coronary artery disease[J]. Arq Bras Cardiol,2018,110(1):16-23. [5] GAUDET D, BRISSON D, WITZTUM J L, et al. Targeting APOC3 in the familialchylomicronemia syndrome[J]. N Engl J Med,2014,371(23):2200-6. [6] LI M R,ZHANG S H,CHAO K,et al. Apolipoprotein C3(-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liverdisease in the Southern Han Chinese population[J]. World Gastroenterol, 2014, 20:14010-14017. [7] RASHEED H, PHIPPS-GREEN A J, TOPLESS R, et al. Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout[J]. Rheumatology (Oxford),2016,55(8):1421-30. [8] WANG M, WANG J, JIANG H. Diagnostic value of apolipoprotein C-I,transthyretin and apolipoprotein C-Ⅲ in gastric cancer[J]. Oncol Lett. 2019,17(3):3227-3232. [9] SEIJKENS T, KUSTERS P, CHATZIGEORGIOU A, et al. Immune cell crosstalk in obesity:a key role for costimulation?[J]. Diabetes,2014,63(12):3982-3991. [10] LELAND L B, ROSHNI S, TRENTON R S, et al. Cholesterol-independent suppression of lymphocyte activation, autoimmunity, and glomerulonephritis by apolipoprotein A-I in normocholesterolemic lupus-prone mice[J]. J Immunol,2015,195(10):4685-4698. [11] HOTMAISLOGOL G S. Inflammation and metabolic disorders[J]. Nature,2007,444(71121):860-867. [12] 刘震超,夏菲菲,周东浩,等. 代谢免疫学:新兴的前沿[J]. 现代免疫学,2018,38(2):166-169. [13] MAKOVEICHUK E, VORRSJÖ E, OLIVECRONA T, et al. Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface[J]. Biochem Bioph Res Commun,2013,441(4):941-946. [14] BANTUG GR,GALLUZZI L,KROEMER G,et al. The spectrum of T cell metabolism in health and disease[J]. Nat Rev Immunol,2018,18:19-34. [15] 李丽,吴长有. 多功能T细胞的检测及其意义[J]. 中国免疫学杂志,2009,25(2):99-102. [16] WANG J,SANTOSUOSSO M,NGAI P,et al. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells[J]. Immunol,2004,173:4590-4597. [17] LANIER L L. NKG2D Receptor and its ligands in host defense[J]. Cancer Immunol Res,2015,3:575-582. [18] LE BERT N, GASSER S. Advances in NKG2D ligand recognition and responses by NK cells[J]. Immunol Cell Biol,2014,92:230-236. [19] DE VLAEMINCK Y,GONZALEZ-RASCON A,GOYVAERTS C, et al. Cancer-Associated myeloid regulatory cells[J]. Front Immunol,2016,7:113. [20] DANIEL K N, JONATHAN Z L, SHERRY N, et al. Monoacylglycerol lipase regulate a fatty acid network that promotes cancer pathogenesis[J]. Cell,2010,32(4):550-570. [21] ROBERT W O, GAREN D G, KEVIN A M, et al. Adipose tissue NK cells manifest and activated phenotype in human obesity[J]. Metabolism,2013,62:1557-1561. |